ReviewCirculation2025
Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care.
Review in Circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis.Journal of human hypertension · 2026Pooled it
- Long-Term Cardiovascular Impact of Postpartum Treatment After Hypertensive Disorders of Pregnancy: Population-Based Cohort Study.BJOG : an international journal of obstetrics and gynaecology · 2026Article
- Postpartum Hypertension: An Important Window of Opportunity to Optimize Maternal Health.Current hypertension reports · 2026Review
- HomeSafe: Postpartum Hypertensive Care Enabled by Electronic Health Record Digital Blood Pressure Capture and Population Health Management.American journal of perinatology · 2026Article
- Association of proprietary smartphone application engagement and attendance at postpartum visit.Proceedings (Baylor University. Medical Center) · 2026Article
- Long-term cardiovascular risks in patients with hypertensive disorders of pregnancy treated with nifedipine or labetalol.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
- Metformin and Hypertensive Disorders of Pregnancy: A Phenotype-Based Focused Narrative Review.Journal of clinical medicine · 2026Review
- Impact of Hypertensive Disorders of Pregnancy on Maternal and Offspring Cardiovascular Health.Current cardiology reports · 2026Review
- Pregnancy as a Window for Hypertension and Cardiovascular Prevention in Women: A Life-Course Perspective Based on the 2025 ESC Guidelines.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Review
- Prenatal remote blood pressure monitoring: Impacts on blood pressure measurement and health outcomes.Pregnancy (Hoboken, N.J.) · 2026Article
- Hypertension-related morbidity after delivery discharge: A comparison of nifedipine versus labetalol.Pregnancy (Hoboken, N.J.) · 2026Article
- RAGE-Mediated Signalling in Gynaecological Disorders: Review of Molecular Mechanisms and Therapeutic Perspectives.Expert reviews in molecular medicine · 2026Review
- Cardiometabolic Health in Pregnancy: Prevention, Management, and Long-Term Implications.JACC. Advances · 2026Review
- Lost in Transition: Postpartum Care Discontinuity and Cardiovascular Risk After Hypertensive Pregnancy.JACC. Advances · 2026Article
- A comparison of the safety of oral labetalol versus nifedipine to manage hypertension in pregnancy in Australia: a target trial emulation.EClinicalMedicine · 2026Article
- Association of Hypertension With Health Care Access and Utilization Following Childbirth: Differences by Race and Ethnicity.JACC. Advances · 2026Article
- Acute-on-chronic liver failure triggered by postpartum variceal bleeding in a patient with alcohol-associated liver disease.Clinical journal of gastroenterology · 2026Article
- Impact of a Postpartum Hypertension Clinic on Cardiovascular Screening After Hypertensive Disorder of Pregnancy.JACC. Advances · 2026Article
- Persistent and de novo postpartum hypertension: a scoping review of pathophysiology, evaluation, and management.NPJ cardiovascular health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.